-
Study aim
-
Selecting the best drug in terms of maximum efficacy in sedation and minimum rate of complications during and after surgery among the drugs studied.
-
Design
-
Clinical trials in two community-based and pragmatic groups with parallel groups, a total volume of 90,double blinded, and randomized
-
Settings and conduct
-
The use of three different drugs with specific doses in three groups and comparing their effect on the sedation level in cataract surgery by phacoamulsification in Feyz Hospital in Isfahan. The patient and Researcher unaware of which drugs are used for each patient.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: patients aged 18 to 90 years undergoing cataract surgery using phacoemulsification methods under local anesthesia and sedation in the first and second classes of the American Anesthetic Association. Exclusion criteria: history of any allergy to the drug used in the design, history of drug addiction, alcohol, benzodiazepine and pregnancy, congestive heart failure, history of head trauma, glaucoma, hypotension, evidence of increased intracranial pressure, psychosis, schizophrenia, active upper respiratory tract infection , Asthma, chronic respiratory disease.
-
Intervention groups
-
Patients in the first group (group D) will receive dexmedetomidine and patients in the second group (group M) will receive midazolam-fentanyl and in the third group (group E) atomidite for sedation during surgery. The sample size in each group was 30 people
-
Main outcome variables
-
Sedation level; drug complications; pain intensity; Arterial blood pressure; oxygen saturation; heart rate; recovery time